Navigation Links
Hybrid Fuels, Inc. Announces New Business Strategy

FORT LAUDERDALE, Fla., Dec. 5, 2011 /PRNewswire/ -- Hybrid Fuels, Inc., (Pink Sheets: HRID) announced today a reorientation of its main business activities and new strategic goals. 

The company will transform itself into a nutraceutical/pharmaceutical business venture that will focus on providing natural or nutraceutical solutions to medical conditions that would normally be treated or addressed with pharmaceutical drugs that are more damaging and can cause side effects that are sometimes even more harmful than the condition being treated.  The company's niche in the market place will be to provide nutraceutical alternatives and solutions to patients ranging from impotence, acne, cholesterol and many other common conditions. 

"Despite globalization, rocky economics and an uneasy healthcare system, the dietary supplement market continues to grow already boasting an estimated $25 billion in U.S. sales.  According to a survey conducted by Ipsos-Public Affairs for the Council for Responsible Nutrition, 65% of adult Americans (approx. 150 million) label themselves as supplement users.  The acquisition of EMG Marketing Solutions was the first step in implementing our new strategic goals focused on this evolving market.  EMB not only brings seasoned leadership in the nutraceutical industry but patented product formulations that are proven to help treat every day health conditions.  We look forward to announcing product lines in production over the next couple of weeks," stated Philip Schmidt, CEO of Hybrid Fuels, Inc.           

About Hybrid Fuels, Inc.

The company was incorporated in the state of Nevada in 1998 as Polo Equities.  It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies. 

Forward-Looking Statements - This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Hybrid Fuels, Inc. undertakes no obligation to update such statements.

Hybrid Fuels, Inc. - 954-903-2993


SOURCE Hybrid Fuels, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hybrid Fuels, Inc. Acquires Marketing Company Focused on Multi-Billion Dollar Nutraceutical/Pharmaceutical Industry
2. MetroSouth Surgeon Pioneers Hybrid Treatment of Large Hiatal Hernias and Reflux
3. Cardicas Automated Anastomosis Systems Featured at Advances In Robotic And Hybrid Coronary Revascularization Meeting
4. Frost & Sullivan Award Highlights Hybridyne Technologies Outstanding Technology Innovation
5. Philips and ACC Address the Growing Demand for Minimally Invasive Cardiology Interventions by Showcasing Hybrid OR Solutions at ACC 2010
6. University of Michigan Study Shows SEQUENOMs MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
7. Ampio Pharmaceuticals Announces Agreement to Acquire Key Drug Delivery Technology
8. WestPark Capital, Inc. Announces $2.6 Million IsoRay Offering
9. WestPark Capital Announces $2.6 Million IsoRay Offering
10. Concord Medical Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting, Board and Management Changes
11. Physicians Capital Investments Announces Pedro Vergne-Marini, MD Named to Beckers ASC Review "350 People in the ASC Industry to Know"
Post Your Comments:
(Date:11/26/2015)... 26, 2015 ) ... Administration of High Viscosity Drugs" report to ... announced the addition of the "Self Administration ... offering. --> Research and Markets ( ... "Self Administration of High Viscosity Drugs" ...
(Date:11/26/2015)... 26, 2015 ... "Radioimmunoassay Market by Type (Reagents & ... Academics, Clinical Diagnostic Labs), Application (Research, Clinical ... 2020" report to their offering. ... addition of the "Radioimmunoassay Market by ...
(Date:11/25/2015)... , Nov. 25, 2015 ... the addition of the "Global Brain ... their offering. --> ) ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) has ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 26, 2015 , ... Ministers, senior government and UN ... African Centres of Excellence, and public R&D institutions, civil societies and other partners ... the 5th African Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders Meeting. The ...
(Date:11/25/2015)... , ... November 25, 2015 , ... According to an ... robot is being more and more widely heralded as a breakthrough for performing hernia ... method has over traditional laparoscopic surgery is that it can greatly reduce the pain ...
(Date:11/25/2015)... ... 2015 , ... On November 25, 2015, officials of Narconon Arrowhead , ... release of a new cutting edge recovery program that has been 50 years in ... and alcohol-addicted individuals with the purpose to free addicts from the symptoms and negative ...
(Date:11/25/2015)... ... ... On November 23rd 2015 Cozy Products, a division of Bird-X ... Products explains what this means for business moving forward. , The Tri Lite heater ... model: to sell personal heaters that reduce energy consumption, are economical and keep people ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Beddit® has ... Beddit Classic sleep tracking systems. The new app features a more intuitive SleepScoreā„¢ that ... understand how well you slept. The SleepScore is created by a proprietary algorithm. Beddit ...
Breaking Medicine News(10 mins):